2,025 results on '"gliosarcoma"'
Search Results
2. Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
3. Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
4. Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
5. Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
6. Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma
7. Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma
8. Engineered NK Cells Containing Deleted TGF-BetaR2 and NR3C1 for the Treatment of Recurrent Glioblastoma
9. Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma
10. Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
11. Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
12. Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer
13. Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
14. Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children
15. Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma
16. Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma
17. TGF-β and BMP signaling are associated with the transformation of glioblastoma to gliosarcoma and then osteosarcoma.
18. Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma
19. Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors
20. Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma
21. Pembrolizumab in Treating Patients With Recurrent Glioblastoma
22. Multiple Doses of Neural Stem Cell Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas
23. Trial of C134 in Patients With Recurrent GBM (C134-HSV-1)
24. A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
25. Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue
26. Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
27. Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG (BRAF)
28. Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma
29. SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
30. hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM) (hSTAR GBM)
31. MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
32. Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma
33. Phase I Study of Marizomib + Panobinostat for Children With DIPG (DIPG)
34. Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma
35. Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy
36. Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma (M032-HSV-1)
37. Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
38. Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1)
39. Study of Pembrolizumab and M032 (NSC 733972)
40. Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
41. Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine®) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma
42. Differentiating Gliosarcoma from Glioblastoma: A Novel Approach Using PEACE and XGBoost to Deal with Datasets with Ultra-High Dimensional Confounders.
43. Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
44. Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma
45. Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
46. Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma (SC9/ABX)
47. Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)
48. Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma
49. Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma
50. A case report: Gliosarcoma associated with a germline heterozygous mutation in MSH2.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.